Company intelligence / Profile preview
Haus Bioceuticals
Oklahoma City, Oklahoma, United Stateshausbio.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Haus Bioceuticals develops clinically active botanical extracts for dermatological conditions. Their products are evidence-based, with some already commercialized and others in clinical development. They use rigorous pharmaceutical R&D processes for natural medicines, including preclinical assessments and clinical trials to evaluate efficacy and safety relative to standard of care.
- Therapeutic areas
- EndocrinologyDermatology
- Modalities
- Botanical extract therapySmall molecule (botanical-derived)
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Beyond the preview
Go deeper on Haus Bioceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Haus Bioceuticals.